News and Trends 27 Feb 2019 UK Biotech Gets Huge Grant to Launch Off-the-Shelf CAR-T Cancer Therapy to Clinic …format costs less money and time to manufacture, which shortens the waiting time for cancer patients. “The patient normally has to wait while their cells are transferred to the manufacturing… February 27, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for …at the last visit at nine months, according to the report. Late last year, Evaxion signed a deal with pharma giant Merck, offering the latter the option to license two… March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 23 Nov 2022 Immune cells in ALS patients can predict the course of the disease …certain types of effector T cells accumulate in the cerebrospinal fluid of ALS patients. “The study could contribute to the development of new treatments that target immune cells to slow… November 23, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 12 Sep 2022 Could combining biotech and photosynthetic cyanobacteria help the energy crisis? …light that no natural living material gives off, not at these wavelengths, and that makes the nanotubes really stand out in these cells.” “Inherited nanobionics” The scientists were able to… September 12, 2022 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 Oct 2023 Six biotech companies in Melbourne that have been making the news …is an immunotherapy that aims to reset immune balance among Treg cells and Th2 cells, regulatory and proinflammatory T cells that tend to be present in varied, unbalanced amounts in… October 31, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Mar 2025 Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next …cancer, exploited by tumor cells to escape destruction. So, by hindering these proteins, checkpoint inhibitors allow the immune system to attack the cancer cells. The most common checkpoint proteins that… March 12, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Jun 2024 Eight biotech companies advancing the field of siRNA …enables the precise delivery of therapeutic agents to specific cells. Aro’s Centyrin technology involves small, stable proteins that are engineered to bind specifically to disease targets. This technology is particularly… June 6, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2022 Reprogramming immune cells can fight melanoma …immune cells encounter cancer cells they are often subverted by the cancer cells and instead tend to nourish them and encourage cancer progression. We wanted to test whether it might… October 31, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 21 May 2018 Engineering Red Blood Cells to Fight the Most Severe Cancers …first cancer therapy using red blood cells. We talked to the CEO, Gil Beyen, to find out how the technology works and what it could mean for the treatment of… May 21, 2018 - 6 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2023 Can stem cell treatment repair damaged knees? …to restore the damaged joints. “Stem cells are very useful if you can put them in the right environment. But if they’re in an environment that’s sort of unfriendly, they’re… August 15, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Startup Scout 21 Feb 2020 This Startup is Developing Anti-Aging Antibodies …small molecule therapies, which is that they could be better at getting rid of the old cells without harming the healthy cells, given the right target. “One of the Holy… February 21, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jan 2023 New drug could replace current standard for treating brain cancer …a clinical drug that sensitizes glioblastoma cells to radiotherapy and could replace temozolomide. Post-surgical radiotherapy and temozolomide, a chemotherapeutic drug, targeting post-cell division is the current standard of care for… January 20, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email